LEADER 06670nam 22008294a 450 001 9910974777103321 005 20250722194941.0 010 $a0-309-16523-7 010 $a1-282-08325-2 010 $a9786612083259 010 $a0-309-54877-2 035 $a(CKB)1000000000030458 035 $a(EBL)3377990 035 $a(SSID)ssj0000284244 035 $a(PQKBManifestationID)11912577 035 $a(PQKBTitleCode)TC0000284244 035 $a(PQKBWorkID)10261069 035 $a(PQKB)11776786 035 $a(DNLM)101245669 035 $a(MiAaPQ)EBC3377990 035 $a(Au-PeEL)EBL3377990 035 $a(CaPaEBR)ebr10089252 035 $a(OCoLC)923274919 035 $a(BIP)53855737 035 $a(BIP)12209011 035 $a(EXLCZ)991000000000030458 100 $a20050411d2005 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt 182 $cc 183 $acr 200 04$aThe smallpox vaccination program $epublic health in an age of terrorism /$fCommittee on Smallpox Vaccination Program Implementation, Board on Health Promotion and Disease Prevention ; Alina Baciu [and others], editors 205 $a1st ed. 210 $aWashington, DC $cNational Academies Press$dc2005 215 $a1 online resource (370 pages) 300 $aSupported by contract no. 200-2000-00629, task order no. 10 between the National Academy of Sciences and the Centers for Disease Control and Prevention. 311 08$aPrint version: Smallpox vaccination program. Washington, DC : National Academies Press, ©2005 (DLC) 2005010062 311 08$a0-309-09592-1 320 $aIncludes bibliographical references and index. 327 $aExecutive Summary -- 1. Smallpox and Smallpox Control in the Historical Context -- 2. Policy Context of Smallpox Preparedness -- 3. The Implementation of the Smallpox Vaccination Program -- 4. Lessons Learned from the Smallpox Vaccination Program -- Appendix A: Recomendations from Letter Reports 1-6 -- Appendix B: Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation Letter Report #1 -- Appendix C: Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation Letter Report #2 -- Appendix D: Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation Letter Report #3 -- Appendix E: Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation Letter Report #4 -- Appendix F: Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program Implementation Letter Report #5 -- Appendix G: Review of the Centers for Disease Control and Prevention's Smallpox Vaccination Program 330 $aDecember 13, 2002, the president of the United States announced that smallpox vaccination would be offered to some categories of civilians and administered to members of the military and government representatives in high-risk areas of the world. The events that precipitated that historic announcement included a series of terrorist attacks during the 1990s, which culminated in the catastrophic events of 2001. Although preparedness for deliberate attacks with biologic weapons was already the subject of much public health planning, meetings, and publications as the twentieth century neared its end, the events of 2001 led to a steep rise in bioterrorism-related government policies and funding, and in state and local preparedness activities, for example, in public health, health care, and the emergency response and public safety communities. The national smallpox vaccination program is but one of many efforts to improve readiness to respond to deliberate releases of biologic agents. The Institute of Medicine (IOM) Committee on Smallpox Vaccination Program Implementation was convened in October 2002 at the request of the Centers for Disease Control and Prevention (CDC), the federal agency charged with implementing the government's policy of providing smallpox vaccine first to public health and health care workers on response teams, then to all interested health care workers and other first responders, and finally to members of the general public who might insist on receiving the vaccine. The committee was charged with providing "advice to the CDC and the program investigators on selected aspects of the smallpox program implementation and evaluation." The committee met six times over 19 months and wrote a series of brief "letter" reports. The Smallpox Vaccination Program: Public Health in an Age of Terrorism constitutes the committee's seventh and final report, and the committee hopes that it will fulfill three purposes: 1) To serve as an archival document that brings together the six reports addressed to Julie Gerberding, director of CDC, and previously released on line and as short, unbound papers; 2) To serve as a historical document that summarizes milestones in the smallpox vaccination program, and ; 3) To comment on the achievement of overall goals of the smallpox vaccination program (in accordance with the last item in the charge), including lessons learned from the program. 606 $aSmallpox$xVaccination$xGovernment policy$zUnited States 606 $aMedical policy 606 $aSmallpox vaccine 606 $aImmunization Programs$xorganization & administration$3(DNLM)D017589Q000458 606 $aSmallpox$xprevention & control$3(DNLM)D012899Q000517 606 $aBioterrorism$xprevention & control$3(DNLM)D023482Q000517 606 $aGovernment Programs$xorganization & administration$3(DNLM)D006078Q000458 606 $aHealth Policy$3(DNLM)D006291 606 $aSmallpox Vaccine$3(DNLM)D012900 607 $aUnited States 615 0$aSmallpox$xVaccination$xGovernment policy 615 0$aMedical policy. 615 0$aSmallpox vaccine. 615 12$aImmunization Programs$xorganization & administration. 615 12$aSmallpox$xprevention & control. 615 22$aBioterrorism$xprevention & control. 615 22$aGovernment Programs$xorganization & administration. 615 22$aHealth Policy. 615 22$aSmallpox Vaccine. 676 $a614.5/21/0973 701 $aBaciu$b Alina$01809957 712 02$aInstitute of Medicine (U.S.).$bBoard on Health Promotion and Disease Prevention 712 02$aInstitute of Medicine (U.S.).$bCommittee on Smallpox Vaccination Program Implementation. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910974777103321 996 $aThe smallpox vaccination program$94409238 997 $aUNINA